In an economic slowdown, investors should own stocks that return cash to shareholders, rather than shares of companies that invest in capital expenditures and in research and development, said Goldman Read more
Tag: Development
Opinion: China’s economy is rotting from the head
BOSTON (Project Syndicate)—China highlights a long-debated question about economic development: Can a top-down autocracy outperform liberal market economies in terms of innovation and growth? Between 1980 and 2019, China’s average Read more
New York has the most expensive rents in the U.S. This city is No. 2…
Rents in Boston are soaring past housing costs in famously pricey California cities like San Francisco and San Jose, making it the country’s second most expensive city for tenants, according to Read more
AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with Faslodex combined with a placebo in a Phase 3 trial in advanced hormone receptor-positive breast Read more
Novartis hemoglobinuria trial meets two primary endpoints
Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug to treat adult paroxysmal nocturnal hemoglobinuria, a red blood cell condition, has met its two primary Read more
App Development For Property Sales: A Complete Guide To Grow Your Real-Estate Business
None can deny the necessity of mobile apps in our lives. While no business sector has remained aloof from the rage of mobile app development, it is on-demand services, food Read more
There’s a new trend in business travel and it’s creating a budding industry
Business travel used to mean sending employees from their home office to somewhere else — to meet with clients or co-workers at other offices. But for many remote-first companies, it Read more
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support for the new bivalent boosters that target the most dominant virus strains and experts are Read more
Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support for the new bivalent boosters that target the most dominant virus strains and experts are Read more
GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine candidate for adults aged over 60 years met its primary endpoint. The U.K.-based maker of Read more